{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:20:41Z","timestamp":1775683241978,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["19K18012"],"award-info":[{"award-number":["19K18012"]}]},{"name":"JSPS KAKENHI","award":["18K08525"],"award-info":[{"award-number":["18K08525"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s13300-022-01313-0","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T14:03:22Z","timestamp":1661436202000},"page":"1779-1788","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type\u00a02 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1882-1814","authenticated-orcid":false,"given":"Hodaka","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Funazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimura","family":"Masahiko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otsuka","family":"Kiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"issue":"6 Suppl","key":"1313_CR1","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.amjmed.2009.03.015","volume":"122","author":"DM Kendall","year":"2009","unstructured":"Kendall DM, Cuddihy RM, Bergenstal RM. Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use. Am J Med. 2009;122(6 Suppl):S37-50.","journal-title":"Am J Med"},{"issue":"6","key":"1313_CR2","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s11892-015-0602-9","volume":"15","author":"D Yabe","year":"2015","unstructured":"Yabe D, Seino Y, Fukushima M, Seino S. \u03b2\u00a0cell dysfunction versus insulin resistance in the pathogenesis of type\u00a02 diabetes in East Asians. Curr Diabetes Rep. 2015;15(6):602.","journal-title":"Curr Diabetes Rep"},{"issue":"Suppl 1","key":"1313_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/jdi.12490","volume":"7","author":"Y Seino","year":"2016","unstructured":"Seino Y, Kuwata H, Yabe D. Incretin-based drugs for type\u00a02 diabetes: focus on East Asian perspectives. J Diabetes Investig. 2016;7(Suppl 1):102\u20139.","journal-title":"J Diabetes Investig"},{"issue":"Suppl 1","key":"1313_CR4","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.diabres.2003.11.024","volume":"66","author":"M Fukushima","year":"2004","unstructured":"Fukushima M, Suzuki H, Seino Y. Insulin secretion capacity in the development from normal glucose tolerance to type\u00a02 diabetes. Diabetes Res Clin Pract. 2004;66(Suppl 1):S37-43.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"1313_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","volume":"17","author":"JE Campbell","year":"2013","unstructured":"Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 2013;17(6):819\u201337.","journal-title":"Cell Metab"},{"issue":"3","key":"1313_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","volume":"3","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ. The biology of incretin hormones. Cell Metab. 2006;3(3):153\u201365.","journal-title":"Cell Metab"},{"issue":"10","key":"1313_CR7","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1507\/endocrj.EJ16-0262","volume":"63","author":"M Kakei","year":"2016","unstructured":"Kakei M, Yoshida M, Dezaki K, et al. Glucose and GTP-binding protein-coupled receptor cooperatively regulate transient receptor potential-channels to stimulate insulin secretion. Endocr J. 2016;63(10):867\u201376.","journal-title":"Endocr J"},{"issue":"6","key":"1313_CR8","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1172\/JCI45680","volume":"121","author":"S Seino","year":"2011","unstructured":"Seino S, Shibasaki T, Minami K. Dynamics of insulin secretion and the clinical implications for obesity and diabetes. J Clin Invest. 2011;121(6):2118\u201325.","journal-title":"J Clin Invest"},{"issue":"1","key":"1313_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1152\/physrev.00008.2017","volume":"98","author":"P Rorsman","year":"2018","unstructured":"Rorsman P, Ashcroft FM. Pancreatic \u03b2-cell electrical activity and insulin secretion: of mice and men. Physiol Rev. 2018;98(1):117\u2013214.","journal-title":"Physiol Rev"},{"issue":"4","key":"1313_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.molmed.2008.01.003","volume":"14","author":"JJ Holst","year":"2008","unstructured":"Holst JJ, Deacon CF, Vilsb\u00f8ll T, Krarup T, Madsbad S. Glucagon-like peptide-1, glucose homeostasis and diabetes. Trends Mol Med. 2008;14(4):161\u20138.","journal-title":"Trends Mol Med"},{"key":"1313_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101102","volume":"46","author":"MA Nauck","year":"2021","unstructured":"Nauck MA, Quast DR, Wefers J, Meier JJ. GLP-1 receptor agonists in the treatment of type\u00a02 diabetes - state-of-the-art. Mol Metab. 2021;46: 101102.","journal-title":"Mol Metab"},{"key":"1313_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.645617","volume":"12","author":"JJ Meier","year":"2021","unstructured":"Meier JJ. Efficacy of semaglutide in a subcutaneous and an oral formulation. Front Endocrinol. 2021;12: 645617.","journal-title":"Front Endocrinol"},{"key":"1313_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108845","volume":"178","author":"M Ohsugi","year":"2021","unstructured":"Ohsugi M, Eiki JI, Iglay K, Tetsuka J, Tokita S, Ueki K. Comorbidities and complications in Japanese patients with type\u00a02 diabetes mellitus: retrospective analyses of J-DREAMS, an advanced electronic medical records database. Diabetes Res Clin Pract. 2021;178: 108845.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"1313_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/jdi.13636","volume":"13","author":"R Bouchi","year":"2022","unstructured":"Bouchi R, Sugiyama T, Goto A, et al. Retrospective nationwide study on the trends in first-line antidiabetic medication for patients with type\u00a02 diabetes in Japan. J Diabetes Investig. 2022;13(2):280\u201391.","journal-title":"J Diabetes Investig"},{"issue":"1","key":"1313_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jdi.13621","volume":"13","author":"N Yagi","year":"2022","unstructured":"Yagi N, Komiya I, Arai K, et al. Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type\u00a02 diabetes mellitus patients and yearly changes in diabetologists\u2019 prescribing patterns from 2002 to 2019 (JDDM61). J Diabetes Investig. 2022;13(1):65\u201373.","journal-title":"J Diabetes Investig"},{"issue":"5","key":"1313_CR16","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/dom.13218","volume":"20","author":"K Kaku","year":"2018","unstructured":"Kaku K, Yamada Y, Watada H, et al. Safety and efficacy of once-weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type\u00a02 diabetes: a randomized trial. Diabetes Obes Metab. 2018;20(5):1202\u201312.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"1313_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/dom.13082","volume":"20","author":"Y Seino","year":"2018","unstructured":"Seino Y, Terauchi Y, Osonoi T, et al. Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type\u00a02 diabetes. Diabetes Obes Metab. 2018;20(2):378\u201388.","journal-title":"Diabetes Obes Metab"},{"issue":"19","key":"1313_CR18","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, et al. Semaglutide and cardiovascular outcomes in patients with type\u00a02 diabetes. N Engl J Med. 2016;375(19):1834\u201344.","journal-title":"N Engl J Med"},{"issue":"5","key":"1313_CR19","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.2337\/dc20-3007","volume":"44","author":"MMY Lee","year":"2021","unstructured":"Lee MMY, Ghouri N, McGuire DK, Rutter MK, Sattar N. Meta-analyses of results from randomized outcome trials comparing cardiovascular effects of SGLT2is and GLP-1RAs in Asian versus white patients with and without type\u00a02 diabetes. Diabetes Care. 2021;44(5):1236\u201341.","journal-title":"Diabetes Care"},{"issue":"2","key":"1313_CR20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s13300-020-00984-x","volume":"12","author":"AB Jain","year":"2021","unstructured":"Jain AB, Kanters S, Khurana R, Kissock J, Severin N, Stafford SG. Real-world effectiveness analysis of switching from liraglutide or dulaglutide to semaglutide in patients with type\u00a02 diabetes mellitus: the retrospective REALISE-DM study. Diabetes Ther. 2021;12(2):527\u201336.","journal-title":"Diabetes Ther"},{"key":"1313_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108931","volume":"178","author":"G Rudofsky","year":"2021","unstructured":"Rudofsky G, Catarig AM, Favre L, et al. Real-world use of once-weekly semaglutide in patients with type\u00a02 diabetes: results from the SURE Switzerland multicentre, prospective, observational study. Diabetes Res Clin Pract. 2021;178: 108931.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"1313_CR22","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/jdi.13773","volume":"13","author":"D Yabe","year":"2022","unstructured":"Yabe D, Yamada Y, Kaku K, Nishida T, Sato T, Seino Y. Efficacy and safety of once-weekly semaglutide in Japanese individuals with type\u00a02 diabetes by baseline age and body mass index. J Diabetes Investig. 2022;13(7):1161\u201374.","journal-title":"J Diabetes Investig"},{"issue":"3","key":"1313_CR23","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s13300-021-01010-4","volume":"12","author":"I Lingvay","year":"2021","unstructured":"Lingvay I, Kirk AR, Lophaven S, Wolden ML, Shubrook JH. Outcomes in GLP-1 RA-experienced patients switching to once-weekly semaglutide in a real-world setting: the retrospective, observational EXPERT study. Diabetes Ther. 2021;12(3):879\u201396.","journal-title":"Diabetes Ther"},{"issue":"3","key":"1313_CR24","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s13300-021-01015-z","volume":"12","author":"DM Williams","year":"2021","unstructured":"Williams DM, Ruslan AM, Khan R, et al. Real-world clinical experience of semaglutide in secondary care diabetes: a retrospective observational study. Diabetes Ther. 2021;12(3):801\u201311.","journal-title":"Diabetes Ther"},{"key":"1313_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01799-2","author":"P Marzullo","year":"2022","unstructured":"Marzullo P, Daffara T, Mele C, et al. Real-world evaluation of weekly subcutaneous treatment with semaglutide in a cohort of Italian diabetic patients. J Endocrinol Invest. 2022. https:\/\/doi.org\/10.1007\/s40618-022-01799-2.","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"1313_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.diabres.2003.10.020","volume":"64","author":"K Kaku","year":"2004","unstructured":"Kaku K, Kawasaki F, Kanda Y, Matsuda M. Retained capacity of glucose-mediated insulin secretion in patients with type\u00a02 diabetes mellitus inversely correlates with the duration of diabetes. Diabetes Res Clin Pract. 2004;64(3):221\u20133.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"1313_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s13300-019-0586-6","volume":"10","author":"A Ohbatake","year":"2019","unstructured":"Ohbatake A, Yagi K, Karashima S, et al. C-peptide area under the curve at glucagon stimulation test predicts glucose improvements by GLP-1 receptor analogue: a retrospective observational study. Diabetes Ther. 2019;10(2):673\u201381.","journal-title":"Diabetes Ther"},{"issue":"3","key":"1313_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/jdi.12906","volume":"10","author":"T Takase","year":"2019","unstructured":"Takase T, Nakamura A, Yamamoto C, et al. Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type\u00a02 diabetes: a randomized controlled trial. J Diabetes Investig. 2019;10(3):699\u2013705.","journal-title":"J Diabetes Investig"}],"updated-by":[{"DOI":"10.1007\/s13300-022-01365-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000}}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-022-01313-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-022-01313-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-022-01313-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T07:28:37Z","timestamp":1673422117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-022-01313-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1313"],"URL":"https:\/\/doi.org\/10.1007\/s13300-022-01313-0","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s13300-022-01365-2","asserted-by":"object"}]},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"assertion":[{"value":"4 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13300-022-01365-2","URL":"https:\/\/doi.org\/10.1007\/s13300-022-01365-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}